InsidersTradesSigma
Discover the detailed record of transactions filed by Moat Ross, Chief Executive Officer. Director active across 1 companies, notably Kiniksa Pharmaceuticals, Ltd.. In total, 2 disclosures have been published. The latest transaction was disclosed on 15 July 2021 (Attribution). Regulator: SEC (Form 4). The full history is accessible without signup.
2 of 2 declarations
Ross Moat is the Chief Commercial Officer at Kiniksa Pharmaceuticals, Ltd. He is responsible for commercial strategy and sales development. Moat leverages his expertise to lead initiatives that support the company's growth.